Visit the institution website for COVID‑19 updates

Entry requirements

2:2 degree (or international equivalent).

Months of entry

September

Course content

The biggest modern breakthrough for cancer treatment has been antibody therapies. An increasing number of biotechnology companies have antibody - or vaccine-based cancer therapies in development. This course aims to attract students interested in tumour immunology who wish to pursue a career either in industry (biotechnology) or academia.